<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Australia Forces Novartis To Withdraw Prexige</title>
	<atom:link href="http://www.pharmalot.com/2007/08/australia-forces-novartis-to-withdraw-prexige/feed" rel="self" type="application/rss+xml" />
	<link>http://www.pharmalot.com/2007/08/australia-forces-novartis-to-withdraw-prexige/</link>
	<description>News, Comment and Conversation</description>
	<pubDate>Mon, 22 Mar 2010 11:21:54 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.2</generator>
		<item>
		<title>By: Pharma News 8_17 &#171; Impactiviti blog</title>
		<link>http://www.pharmalot.com/2007/08/australia-forces-novartis-to-withdraw-prexige/#comment-17136</link>
		<dc:creator>Pharma News 8_17 &#171; Impactiviti blog</dc:creator>
		<pubDate>Fri, 17 Aug 2007 12:18:34 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2007/08/australia-forces-novartis-to-withdraw-prexige/#comment-17136</guid>
		<description>[...] Novartis takes a hit on Prexige (COX-2 inhibitor); withdrawn in Australia. [...]</description>
		<content:encoded><![CDATA[<p>[...] Novartis takes a hit on Prexige (COX-2 inhibitor); withdrawn in Australia. [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Hypocrisy rules</title>
		<link>http://www.pharmalot.com/2007/08/australia-forces-novartis-to-withdraw-prexige/#comment-16821</link>
		<dc:creator>Hypocrisy rules</dc:creator>
		<pubDate>Sun, 12 Aug 2007 21:58:07 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2007/08/australia-forces-novartis-to-withdraw-prexige/#comment-16821</guid>
		<description>There have been several comments re this drug and how it relates to Vioxx. In fact this writer has worned about this new Vioxx immediately after its intro into the first country and especially  after it hit the N. American markets. The drug itself may not be as bad as reported here but what is wrong Novartis' promotion to every doc and to every patient with OA. This drug has a very limitted and narrow indication, OA of the knees, period. 
Does anyone in their right mind think that Novartis with their multiple sales forces for specialists and GPs would limit the promo of their Vioxx to its narrow indication? Not bloody likely.
When you have thousands upon thousands of inocent patients/people on the drug like this one without good and right reason you are likely to see these side effects. 
On personal note. I was Rxed Prexige by my GP for the pain in my shoulder. Did nothing for me so I luckily stopped and switched to ASA with complete success. My doctor was told by the reps ( yes plural) thagt it was OK to Rx it to anyone with pain of OA.
Off label, false claim you take a pick. It never stops with these "people".</description>
		<content:encoded><![CDATA[<p>There have been several comments re this drug and how it relates to Vioxx. In fact this writer has worned about this new Vioxx immediately after its intro into the first country and especially  after it hit the N. American markets. The drug itself may not be as bad as reported here but what is wrong Novartis&#8217; promotion to every doc and to every patient with OA. This drug has a very limitted and narrow indication, OA of the knees, period.<br />
Does anyone in their right mind think that Novartis with their multiple sales forces for specialists and GPs would limit the promo of their Vioxx to its narrow indication? Not bloody likely.<br />
When you have thousands upon thousands of inocent patients/people on the drug like this one without good and right reason you are likely to see these side effects.<br />
On personal note. I was Rxed Prexige by my GP for the pain in my shoulder. Did nothing for me so I luckily stopped and switched to ASA with complete success. My doctor was told by the reps ( yes plural) thagt it was OK to Rx it to anyone with pain of OA.<br />
Off label, false claim you take a pick. It never stops with these &#8220;people&#8221;.</p>
]]></content:encoded>
	</item>
</channel>
</rss>
